IPG Photonics Corp header image

IPG Photonics Corp

IPGP

Equity

ISIN US44980X1090 / Valor 1196227

NASDAQ (2024-11-22)
USD 77.79+3.98%

IPG Photonics Corp
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

IPG Photonics Corp, founded in 1991 by physicist Valentin P. Gapontsev, Ph.D., is a leading developer and manufacturer of high-performance fiber lasers and amplifiers for various applications in multiple markets. Originally focusing on customized glass and crystal lasers, wireless temperature meters, and laser components, the company shifted its focus to high-power fiber lasers and amplifiers in the early 1990s. With a global presence, IPG's diverse lines of low, medium, and high-power lasers and amplifiers are utilized in materials processing, communications, entertainment, medical, biotechnology, scientific, and advanced applications, displacing traditional technologies. The company, which went public in 2006 and is listed on the NASDAQ Global Select Market, invests in high-capacity production facilities to manufacture its own laser diode pumps, ensuring quality and reliability in its products.

Summarized from source with an LLMView SourceSector: Technology

Latest Results (14.08.2024):

Revenue Decline

IPG Photonics Corp reported a revenue of $257.6 million for the second quarter of 2024, marking a 24% decrease compared to the same period in 2023. The decline was influenced by changes in foreign exchange rates, which reduced revenue by approximately $6 million or 2%. Regionally, sales decreased 2% in North America, 34% in China, 27% in Europe, and 39% in Japan.

Gross Margin Reduction

The gross margin for IPG Photonics Corp in the second quarter of 2024 was 37.3%, a decrease of 610 basis points from the previous year. This reduction was primarily due to lower absorption of manufacturing expenses and increased inventory reserves, although it was partially offset by lower tariffs and shipping costs.

Net Income and EPS

IPG Photonics Corp's net income attributable to the company for the second quarter of 2024 was $20.2 million, a 68% decrease from the same quarter in 2023. Earnings per diluted share (EPS) also saw a significant drop, coming in at $0.45, down 66% year over year.

Cash Flow and Expenditures

During the second quarter of 2024, IPG Photonics Corp generated $53 million in cash from operations. The company spent $24 million on capital expenditures and $122 million on share repurchases, reflecting its focus on financial execution and cash generation.

Business Outlook

For the third quarter of 2024, IPG Photonics Corp expects revenue to be between $210 million and $240 million. The company anticipates a gross margin between 34% and 37%, with operating expenses ranging from $82 million to $84 million. The expected earnings per diluted share are projected to be in the range of $0.00 to $0.30.

Summarized from source with an LLMView Source

Key figures

-18.6%1Y
-52.6%3Y
-44.2%5Y

Performance

35.1%1Y
39.3%3Y
43.4%5Y

Volatility

Market cap

3235 M

Market cap (USD)

Daily traded volume (Shares)

63,576

Daily traded volume (Shares)

1 day high/low

75.6 / 73.24

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Sage Therapeutics Inc
Sage Therapeutics Inc Sage Therapeutics Inc Valor: 24747713
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
6.60%USD 5.17
Gogo Inc
Gogo Inc Gogo Inc Valor: 14665669
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.93%USD 8.12
Maravai LifeSciences Holdings Inc
Maravai LifeSciences Holdings Inc Maravai LifeSciences Holdings Inc Valor: 58353451
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
5.24%USD 5.22
Digital Turbine Inc
Digital Turbine Inc Digital Turbine Inc Valor: 25638656
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.40%USD 1.52
Prime Medicine Inc
Prime Medicine Inc Prime Medicine Inc Valor: 122054714
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
7.74%USD 3.20
LegalZoom.com Inc
LegalZoom.com Inc LegalZoom.com Inc Valor: 19113587
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.90%USD 7.83
Myriad Genetics Inc
Myriad Genetics Inc Myriad Genetics Inc Valor: 338449
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.45%USD 15.49
ABB Ltd
ABB Ltd ABB Ltd Valor: 1222171
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.17%CHF 50.16
BELIMO Holding Ltd
BELIMO Holding Ltd BELIMO Holding Ltd Valor: 110109816
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.75%CHF 580.50
SFS Group Ltd
SFS Group Ltd SFS Group Ltd Valor: 23922930
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.47%CHF 124.60